GHO Capital Acquires Majority Stake in Sterling Pharma Solutions

GHO Capital and Partners Group Invest in Sterling Pharma Solutions

May 25, 2023

Pharmaceuticals

GHO Capital (majority owner) and Partners Group have completed an investment into GHO portfolio company Sterling Pharma Solutions, with Partners Group acquiring a significant minority stake. The transaction is supported by a consortium led by funds managed by AlpInvest Partners and Pantheon and will fund Sterling's expansion of production capacity, capability build-out and further strategic acquisitions across the UK, Europe and the US.

Sterling Pharma Solutions Acquires Novartis Ringaskiddy API Manufacturing Facility

January 11, 2023

Pharmaceuticals

Sterling Pharma Solutions, a GHO Capital portfolio company, has completed the acquisition of the Novartis API manufacturing facility in Ringaskiddy, County Cork, Ireland. The 111-acre site (with ~350 transferred employees and extensive commercial-scale API production capacity) expands Sterling's European manufacturing footprint and includes an ongoing supply agreement with Novartis.

Sterling Pharma Solutions Acquires Alcami's Germantown (WI) API Facility

October 1, 2020

Pharmaceuticals

Sterling Pharma Solutions, a portfolio company of GHO Capital Partners, has acquired Alcami’s Germantown, Wisconsin API development and manufacturing facility. The facility expands Sterling’s US footprint and adds cGMP capacity for complex and hazardous API projects, including plant-scale hydrogenation and cryogenic reactions.

Sterling Pharma Solutions Acquires ADC Biotechnology

April 7, 2021

Biotechnology

Sterling Pharma Solutions, a GHO Capital portfolio CDMO, has acquired ADC Biotechnology (ADC Bio), a Deeside-based bioconjugation and ADC development services business. The deal adds ADC capabilities and a Deeside facility to Sterling’s international network and includes multi-million pound investment to grow bioconjugation, analytical and cGMP ADC manufacturing capabilities.

GHO Capital Leads Consortium to Acquire Majority Stake in Envision Pharma Group from Ardian

November 5, 2020

Healthcare Services

GHO Capital Partners, leading a consortium that includes Mubadala Investment Company, HarbourVest Partners and Northwestern Mutual, together with Envision management and employees, has acquired a majority stake in Envision Pharma Group as Ardian exits its investment. The transaction will support Envision's continued growth, wider rollout of its iEnvision medical affairs platform and strategic acquisitions to expand its medical affairs, communications and technology capabilities.

Sterling Pharma Solutions Acquires CiVentiChem US Facility in Cary, North Carolina

April 3, 2019

Pharmaceuticals

UK-based CDMO Sterling Pharma Solutions, a portfolio company of GHO Capital, has acquired the CiVentiChem US facility in Cary, North Carolina to establish a local presence for its North American clients and expand its chemistry development and kilo-scale cGMP capabilities. The acquisition supports Sterling’s strategy to build a global chemistry services business and follows GHO Capital’s majority investment in Sterling earlier this year.